(281)-719-8904 KenFaulkenberry@AAAMP.com

Cardinal Health (CAH) Dividend Stock Analysis

by | Dividend Aristocrats

Cardinal Health Dividend

(updated 12/08/2017)

The Cardinal Health (CAH) dividend has been paid since 1983 and increased for 31 consecutive years;
qualifying the company as a Dividend Aristocrat.

Price: $58.89
Current Annual Dividend: $1.8496

Dividend Yield: 3.1%
Cash Dividend Payout Ratio: 30%

Market Capitalization: 19 B
Enterprise Value: 27 B


Sector: Health Care
Industry: Medical Distribution

Cardinal Health (CAH) is a healthcare and medical products distributor to 20,000 Pharmacies, 5000 pharmaceutical and medical suppliers, and 1.8 million home healthcare patients. The company manufactures or sources more than 2.5 billion individual consumer healthcare, home medical equipment, and over-the-counter products.

With close to 35,000 employees you might say Cardinal Health is the “everywhere” healthcare company. From the company annual report: “Cardinal Health helps customers reduce costs, increase efficiency, and improve quality, outcomes and access. From hospitals to home and everywhere in between, we serve the entire continuum of care with logistics, business, product and patient solutions”.

Dividend Analyzer Checklist

(updated November 2017)

Dividend Safety Score (22/33 points)

Dividend Payout Ratio (ttm): 53%
Cash Dividend Payout Ratio (ttm): 30%  (11/12 points)
Dividend Per Share (ttm):  $1.81
Cash From Operations (CFO) Per Share (ttm): $7.09
Free Cash Flow (FCF) Per Share (ttm): $5.98
Net Financial Debt: 8822 M
Total Assets: 41940 M
Net Financial Debt / Total Assets:  21% (7/12 points)
Net Financial Debt to EBITDA (ttm): 281%
Piotroski Score (1-9) (TTM): (4/9 points)


Profitability Score (19/33 points)

Operating Earnings Yield (ttm): 10.3% (14/15 points)
Net Income (ttm): $1094
Gross Profit (ttm): $6625
Total Assets: $41940
Gross Profitability Ratio = GP / Total Assets: 16% (5/18 points)
Cash Return On Invested Capital (CROIC)(tttm): 14%
Return on Invested Capital (ROIC): 8%

Valuation Score (26/34 points)

Free Cash Flow Yield (ttm):  10.5%  (17/17 points)
EV to EBIT (ttm): 14.4
EV to EBITDA (ttm):  10.1  (9/17 points)
Price to Sales Ratio (ttm): 0.2
Price to Book Value (ttm): 2.9
Price to Earnings Ratio (P/E) (ttm): 15
PE 10:  22

TOTAL POINTS – (67/100) (50 is an average score)

Earnings Report: 11/06/17
Next Earnings Report: 2/07/18

Stay Updated All the Time!

Dividend Safety, Profitability, and Valuation Scores for 300+ Dividend Stocks Each Month. 

Fundamental Quantitative Analysis to Find the "Hidden Gems".

Six Dividend Portfolios (Stocks & ETFs).

Learn More

SWOT Analysis


The massive $300 billion retail pharmaceutical business is only going to grow for the foreseeable future. Distribution operations are controlled by three companies (Cardinal Health, AmerisourceBergen, and McKesson) with 90% market share.

CAH competitive advantages include economies of scale, being a low cost provider (deep pricing discounts from drug manufacturers), and barriers to entry (enormous distribution system).


The healthcare industry is extremely dynamic. Pressure to lower costs are coming from government, suppliers, retailers, and consumers. Regulations (including increased transparency) and procedures are in constant flux.

This is a business with ultra thin margins. While this keeps new competitors from entering the medical distribution industry, it leaves no room for error or unforeseen changes that disrupt profits.


The 10 years agreement with CVS Caremark to combine generic sourcing operations is an example of how CAH can use its size and expertise to lock in business. Partnerships offer opportunities to improve profit margins and provide lower costs to consumers.


Large contracts tie large percentages of business to one customer. Contracts lost with Walgreens in 2013 and Express Script in 2012 had a significant impact on business operations. CVS health currently represents over 40% of CAH sales. One word: Amazon.


(updated November 2017)

Cardinal Health (CAH) is ranked #51 (out of 377) overall and 4 (out of 31) in the Healthcare sector by the Dividend Analyzer.

Type of Investor / Recommendation

Large Diversified Dividend Portfolios /  Should be Considered
Looking For Exposure to Healthcare Sector / Can Be Considered
Deep Value Investors / Watchlist

Portfolio Position Disclosures:
DVB Foundation Portfolio – None
DVB Dividend Growth – None
DVB High Income – None
Arbor Asset Allocation Model Portfolio (AAAMP) – None

Discover, Compare, and Evaluate Dividend Stocks Without Emotional Bias


Dividend Analyzer Newsletter: Total Score, Dividend Safety Score, Profitability Score, and Valuation Score for 300+ dividend stocks.

Treasure Trove Twelve: Find the Hidden "Gems" in the Midst of 1000's of stock choices. DVB Database Sector Analysis.

DVB Portfolio Newsletter: Three Stock Portfolios, One Page Summaries For Each DVB Portfolio Stock With a Buy Ranking. Email Notification of Portfolio Changes.

Free 7-Day Trial. You take NO risk. Start today!

Learn More
Disclaimer: While Arbor Investment Planner has used reasonable efforts to obtain information from reliable sources, we make no representations or warranties as to the accuracy, reliability, or completeness of third-party information presented herein. The sole purpose of this analysis is information. Nothing presented herein is, or is intended to constitute investment advice. Consult your financial advisor before making investment decisions.
Share This